Furthermore, there was a trend for the association between older age and lower anterior–superior volume to be stronger for APOE ε4 homozygotes and heterozygotes than non‐carriers, suggesting that this subunit may be vulnerable to volume loss from AD pathology. This evidence concerns the gene APOE and Alzheimer disease.